Condition

Uterine Cancer

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 40 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials40
Recruiting6
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

40 shown
Sample Collection for Ongoing Research and Product Evaluation StudyNCT07318051 · 2025-07-21
RECRUITING
Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenNCT06904365 · 2025-04-08
RECRUITING
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)NCT05579366 · 2022-12-07
RECRUITING
NYSCF Scientific Discovery BiobankNCT06203106 · 2022-11-10
RECRUITING
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsNCT04038619 · 2021-02-01
RECRUITING
Liquid Biopsy Evaluation and Repository Development at Princess MargaretNCT03702309 · 2017-08-03
RECRUITING
COQ10 and Vitamin E for Off-Target Radiation ToxicityNCT07668284 · 2026-07-01
NOT_YET_RECRUITING
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid MalignanciesNCT07542704 · 2026-05-01
NOT_YET_RECRUITING
Enhanced Assistance During Radiotherapy for Unmet Essential NeedsNCT06582849 · 2024-10-04
COMPLETED
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsNCT05864144 · 2023-05-31
COMPLETED
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)NCT05708950 · 2023-03-03
COMPLETED
Interventions to Decrease Financial ToxicityNCT05939440 · 2022-06-01
COMPLETED
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic MalignanciesNCT03762733 · 2022-01-04
ENROLLING_BY_INVITATION
The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETED
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineNCT05697198 · 2021-04-19
COMPLETED
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNCT04604158 · 2020-12-02
COMPLETED
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsNCT04383210 · 2020-09-29
TERMINATED
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsNCT04424641 · 2020-07-15
TERMINATED
Effect of Hemp-CBD on Patients With CIPNNCT04398446 · 2020-05-27
UNKNOWN
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the TumourNCT03934827 · 2019-04-10
UNKNOWN
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsNCT03924466 · 2019-04-01
UNKNOWN
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial CancerNCT03694834 · 2019-03-29
TERMINATED
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)NCT03896958 · 2019-03-21
UNKNOWN
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine CancerNCT04239443 · 2019-01-30
UNKNOWN
Study of NEO-201 in Solid Tumors Expansion CohortsNCT03476681 · 2019-01-18
ACTIVE_NOT_RECRUITING
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsNCT03662204 · 2018-08-23
COMPLETED
Laser Fluorescence in Cancer Surgical TreatmentNCT03021200 · 2016-07-12
UNKNOWN
Pilot Study of Durvalumab and Vigil in Advanced Women's CancersNCT02725489 · 2016-06-03
COMPLETED
A Mind-body Intervention to Improve Body and/or Self ImageNCT02531997 · 2015-08-01
COMPLETED
Pillars4Life TrialNCT02465892 · 2015-05-01
COMPLETED
Strength Training Study for Survivors of Breast and Gynecologic CancerNCT01709175 · 2012-11-01
COMPLETED
Cancer and Mindfulness-Based Cancer Recovery After ChemotherapyNCT01601548 · 2012-07-01
COMPLETED
Assisted Exercise in Obese Endometrial Cancer PatientsNCT01870947 · 2011-09-07
COMPLETED
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid TumorsNCT01176500 · 2010-07-28
WITHDRAWN
Heated Chemotherapy for Cancers That Have Spread to the Chest CavityNCT01163552 · 2010-06-01
COMPLETED
Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under RadiotherapyNCT01570218 · 2010-02-01
COMPLETED
Comparison of Standard of Care or Treatment on ProtocolNCT01010334 · 2009-03-01
TERMINATED
The RECHARGE Low Carbohydrate Diet Trial for Metastatic CancerNCT00444054 · 2006-02-01
COMPLETED
Study of D-Methadone in Patients With Chronic PainNCT00588640 · 2004-10-01
COMPLETED
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerNCT00588263 · 2000-07-01
WITHDRAWN

Common interventions

Trial status mix

COMPLETED18
RECRUITING6
UNKNOWN6
TERMINATED4
NOT_YET_RECRUITING2
WITHDRAWN2
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1

Phase mix

PHASE214
NA12
PHASE111
EARLY_PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.